demethoxymatteucinol - Names and Identifiers
demethoxymatteucinol - Physico-chemical Properties
Molecular Formula | C17H16O4
|
Molar Mass | 284.31 |
Density | 1.307±0.06 g/cm3(Predicted) |
Melting Point | 200 °C |
Boling Point | 524.1±50.0 °C(Predicted) |
Appearance | Yellow powder |
pKa | 8.20±0.40(Predicted) |
Storage Condition | 2-8℃ |
demethoxymatteucinol - Introduction
Demethoxymatteucinol is a natural product belonging to a class of compounds known as methoxyflavones. It is derived from a number of plants, such as the Southern Springwood family and some other plants.
The chemical structure of Demethoxymatteucinol contains benzene ring and benzofuran ring, which has certain aromaticity. Its physical properties include a colorless crystalline solid with a melting point of about 120-125°C.
The compound has several potential uses in the medical field. Studies have shown that Demethoxymatteucinol has some biological activities, including anticancer, antioxidant, anti-inflammatory and antibacterial activities. However, more research and validation is needed for its specific medical use.
Regarding the preparation method of Demethoxymatteucinol, it is generally obtained by extracting from plants. The specific extraction method may vary depending on the source of the plant. Generally, it involves extracting the plant material with an organic solvent (e. G., methanol, ethanol, etc.), and then obtaining the target compound through the steps of concentration, isolation, and purification. The specific steps of the preparation method can be optimized and improved according to actual needs.
At present, the safety information on Demethoxymatteucinol is still relatively limited, and there is no detailed toxicity evaluation and safety report for reference. Therefore, caution is required when using this compound. In the process of experimental research or drug development, it is necessary to follow relevant scientific experiments and safe operation specifications. If it needs to be applied to clinical or other fields, adequate pharmacokinetic and toxicological studies should be carried out to ensure its safety and effectiveness. In addition, special groups such as personal allergy history, pregnant women and children should be treated with caution to avoid potential adverse effects.
Last Update:2024-04-09 21:54:55